In addition, CXCL13-expressing CD8+ T cells are linked to the proinflammatory features of macrophages and show enhanced cytotoxicity following anti-PD-L1 therapy in triple-negative breast cancer [198]. This evidence concerns the gene CXCL13 and triple-negative breast carcinoma.